co.don AG EV / EBITDA
Was ist das EV / EBITDA von co.don AG?
EV / EBITDA von co.don AG ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf XETRA im Vergleich zu co.don AG
Was macht co.don AG?
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Unternehmen mit ev / ebitda ähnlich co.don AG
- Metalex Ventures hat EV / EBITDA von N/A
- Minfocus Exploration hat EV / EBITDA von N/A
- Advance Gold hat EV / EBITDA von N/A
- Rincon Resources hat EV / EBITDA von N/A
- Argent Minerals hat EV / EBITDA von N/A
- Protokinetix hat EV / EBITDA von N/A
- co.don AG hat EV / EBITDA von N/A
- Central Timmins Exploration hat EV / EBITDA von N/A
- Kin Pang hat EV / EBITDA von N/A
- Bossini International hat EV / EBITDA von N/A
- Ecofibre hat EV / EBITDA von N/A
- e Actiplay SA hat EV / EBITDA von N/A
- Fox Marble PLC hat EV / EBITDA von N/A